GBM
Clinical trials for GBM explained in plain language.
Never miss a new study
Get alerted when new GBM trials appear
Sign up with your email to follow new studies for GBM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Dual-Attack strategy targets deadly brain tumors
Disease control Not yet recruitingThis study tests a two-part treatment for a very aggressive type of brain tumor that spreads to both sides of the brain. Doctors will surgically remove as much tumor as possible from one side, then use a minimally invasive laser to heat and destroy tumor tissue on the other side.…
Matched conditions: GBM
Phase: NA • Sponsor: King's College Hospital NHS Trust • Aim: Disease control
Last updated Apr 02, 2026 05:41 UTC
-
Sound waves target brain cancer in new treatment trial
Disease control Not yet recruitingThis study is testing whether a device called the NaviFUS system, which uses focused ultrasound, is safe and might help when used with the standard drug bevacizumab for adults with glioblastoma (GBM) that has come back. The ultrasound is meant to temporarily open the blood-brain …
Matched conditions: GBM
Phase: NA • Sponsor: University of Cincinnati • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for deadly brain cancer: experimental drug enters human trials
Disease control Not yet recruitingThis early-stage trial is testing a new drug called LMP744 in adults whose aggressive brain cancer (glioblastoma) has returned after standard treatment. The main goal is to see if the drug can shrink tumors and slow the cancer's progression. Participants will receive the drug thr…
Matched conditions: GBM
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
New hope for fighting deadly brain tumors: experimental drug combo enters testing
Disease control Not yet recruitingThis study is testing whether adding a new oral drug called silevertinib to standard chemotherapy (temozolomide) helps people with a specific type of aggressive brain cancer (glioblastoma) live longer without their cancer getting worse. It will involve about 162 newly diagnosed p…
Matched conditions: GBM
Phase: PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC
-
Early trial tests common Drug's effect on deadly brain cancer
Knowledge-focused Not yet recruitingThis early research study aims to understand how Acetadote affects metabolism in glioblastoma brain tumors. Researchers will give Acetadote to 10 newly diagnosed patients before surgery, then analyze tumor tissue and MRI scans to see how the drug changes tumor chemistry. The goal…
Matched conditions: GBM
Phase: EARLY_PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC